Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-containing Regimens in Real-life Clinical Care in Europe (CMPASS-EU)
Clinical trial NCT02368522 · COMPLETED
Trial details
- NCT number
- NCT02368522
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-12-01
- Primary completion
- 2017-02-01
- Enrollment
- 920
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.